 |
 |
|
Home |
Current Issue |
Past Issues |
Audio/Video |
CME |
Collections |
In the Clinic |
Mobile |
Subscribe |
Tools |
Help |
ACP Online
|
|
Articles 
Richard B. Alexander, Kathleen J. Propert, Anthony J. Schaeffer, J. Richard Landis, J. Curtis Nickel, Michael P. O'Leary, Michel A. Pontari, Mary McNaughton-Collins, Daniel A. Shoskes, Craig V. Comiter, Nand S. Datta, Jackson E. Fowler, Jr, Robert B. Nadler, Scott I. Zeitlin, Jill S. Knauss, Yanlin Wang, John W. Kusek, Leroy M. Nyberg, Jr, Mark S. Litwin and the Chronic Prostatitis Collaborative Research Network* In this placebo-controlled trial, ciprofloxacin and tamsulosin (an
Lisa B. Kenney, Yutaka Yasui, Peter D. Inskip, Sue Hammond, Joseph P. Neglia, Ann C. Mertens, Anna T. Meadows, Debra Friedman, Leslie L. Robison, and Lisa Diller Survivors of childhood sarcomas and those who received chest radiation therapy are at increased risk for secondary breast cancer. Factors influencing a survivor's risk include the specific type of cancer experienced during childhood, previous radiation therapy, family cancer history, and history of thyroid disease.
Lucy Yardley, Margaret Donovan-Hall, Helen E. Smith, Bronagh M. Walsh, Mark Mullee, and Adolfo M. Bronstein In this randomized trial, vestibular rehabilitation exercises, taught by nurses in general practice and performed at home, improved symptoms, postural stability, and dizziness-related disability in patients with chronic dizziness.
Improving Patient Care
Robert Frank DeBusk, Nancy Houston Miller, Kathleen Marie Parker, Albert Bandura, Helena Chmura Kraemer, Daniel Joseph Cher, Jeffrey Alan West, Michael Bruce Fowler, and George Greenwald In this clinical trial, nurse care management for patients with heart failure at low risk for rehospitalization did not reduce rehospitalizations for heart failure or for any cause. Most care management programs have targeted patients at high risk for rehospitalization. These programs may be less effective for patients at low risk.
Updates
Robert O. Bonow This Update covers risk factors for heart disease, new treatment approaches for coronary artery disease, treatment for reducing cardiovascular risk, and treatment of chronic heart failure.
Reviews
Lizzy M. Brewster, Gert A. van Montfrans, and Jos Kleijnen Although some antihypertensive drugs affect blood pressure differently in black patients and white patients, efficacy for reducing morbidity and mortality is the same once patients achieve a blood pressure goal.
Perspectives
Saif S. Rathore and Harlan M. Krumholz Studies often document racial differences in health care use, but most lack a framework for interpreting these variations. Ambiguity impedes understanding of whether differences reflect innocuous variations or significant shortfalls in care. To address this issue, we propose terminology and criteria for assessing reports of racial differences in health care use.
Editorials
Wolfgang Weidner In Alexander and colleagues' large, well-performed randomized trial, neither a broad-spectrum antibiotic nor an
Marianne Dieterich The convincing study by Yardley and colleagues in this issue broadens our knowledge of treating dizziness and provides strong arguments to get our patients up and exercising.
Edward H. Wagner The nurses in the heart failure disease management intervention tested in DeBusk and colleagues' study contacted the patients only by telephone. The failure of this program to alter congestive heart failure outcomes should cause policymakers to question the rush to telephone-only disease management programs.
On Being a Patient
Michael D. Martin Try as he might, he just couldn't figure things out. Everything seemed backward or upside down or something. In a way this felt like home, but this wasn't home. He wasn't old like these other people, and he had a wife and kids and a job to go to.
Letters Inhaled Corticosteroids and Adrenal Function
Hand Hygiene
Limitations of Gold Standards for Diagnosing Gastroesophageal Reflux Disease
Ezetimibe and Statin-Associated Myopathy
Screening for Lung Cancer
Senna-Induced Hepatitis in a Poor Metabolizer
E. Richard Blonsky
William H. Kober
D. A. Feinfeld
Rae Varcoe
| ||||||||||||||||||||||||||||||||||||||||||||||||
In this Issue
Articles
Previous Issue
-adrenergic blocker) did not substantially reduce symptoms in men with moderate to severe symptoms from long-standing chronic prostatitis/chronic pelvic pain syndrome. 